The need for a new RVH This oration, and the record of it for publication, mainly focuses on the new Royal Victoria Hospital building opened officially on 2 September 2003, but it is interesting to compare and contrast the needs of the Royal Victoria Hospital at the ends of the 19th and 20th centuries. At both times there was increasing dissatisfaction with the hospital's accommodation while the demands on the hospital were increasing rapidly. For example, it was felt that more complicated surgery was much safer in a central facility. In 1900 this was the contrast between home and hospital surgery while towards 2000 the need for intensive facilities for complex major operations was apparent. In both eras the case for a new build was compelling but finances were a major issue. The process for the move to the RVH site and the process for the new build in 2004 had similarities. Firstly, the site of the rebuild had to be established (Figs. 1 and 2) . Secondly, it was necessary to change the management of nursing. Thirdly, it was vital to involve medical staff. On both occasions members of the RVH medical staff were closely involved in decisions on the type of hospital and the facilities needed. Even 100 years later one has to acknowledge the dedication and fund raising ability of Lady Pirrie who was instrumental in raising the capital required to allow a foundation stone to be laid in 1901 been that this was pretty far from the real killer disease of hypertension and probably irrelevant to less specific forms of hypertension than renal artery disease. It could also be dismissed as pretty much animal research work or as blue sky research with little application to the Department of Health or to a University. However, ongoing work in which I was privileged to play a small part has led to the development of angiotensin converting enzyme (ace) inhibitors, angiotensin receptor blockers, aldosterone antagonists and combination of these drugs with other drugs such as diuretics has been shown to have an important effect in reducing morbidity and mortality in hypertension, cardiac failure, myocardial infarction, incipient and established diabetic kidney disease (Fig 5) . Severe cases of refractory hypertension can be controlled with a combination of ace inhibitor and high dose loop diuretic,4 while in the Hypertension in Diabetes Study of the United Kingdom Prospective Diabetes Study (UKPDS), the tight blood pressure control groups, one of which was based on therapy based on the use of ace inhibitors, reduced risk for any diabetes related end-point by 24%, with a 32% reduction in diabetes related deaths, 44% in stroke, 37% in macrovascular disease, 56% in heart failure and 34% in retinopathy progression over an eight year period.5 Another implication for this UKPDS study is that multicentre drug studies such as this are often not just simply drug studies but answer vital and fundamental pathophysiological questions which emphasis on investigative medicine and on the appropriate funding and facilities for this is essential to the future of the Royal Group of Hospitals. This together with adequately staffed specialist teams throughout the hospital will enhance our care of patients and allow us to be a teaching hospital fit for the new century.
